Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Cureus ; 13(12): e20395, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-35036225

RESUMO

Hepatic dysfunction in the setting of infectious mononucleosis has been documented in the literature. However, clinically significant jaundice and direct hyperbilirubinemia are rarely associated with this infection. In the instance of undetermined underlying diagnosis and hepatic enzyme derangement, this may pose a diagnostic challenge. Furthermore, several diagnostic tests may be indicated, which could potentially increase resource consumption in any hospital setting. This case report aims to remind physicians that infectious mononucleosis may be a cause of hyperbilirubinemia, which does not usually require further complex testing other than monitoring and supportive therapy.

2.
J Acquir Immune Defic Syndr Hum Retrovirol ; 19(5): 513-8, Dec. 15, 1998.
Artigo em Inglês | MedCarib | ID: med-1363

RESUMO

OBJECTIVES: To determine the seroprevalence of, and risk factors for, HTLV-I and HTLV-II infection among HIV-infected women and women at high risk for HIV infection. DESIGN: Cross-sectional analysis of baseline data for women enrolled in the prospective Women's Interagency HIV Study (WIHS). METHODS: From October 1994 through November 1995, 2657 women from five metropolitan areas in the United States (Chicago, Los Angeles, New York City [two sites], Northern California, and Washington DC) were enrolled in WIHS. An interview-based survey collected data on demographics, behavior, and medical history. HTLV-I and HTLV-II determinations were made using a combined HTLV-I/HTLV-II indirect immunofluorescent antibody (IFA) screening test, an IFA titration specificity test, and individual HTLV-I and HTLV-II confirmatory Western blots. Fisher's exact tests and logistic regression were used to determine univariate and multi variate independent predictors for HTLV-II infection. RESULTS: Of 2625 women enrolled in WIHS with confirmed HIV results, 2487 (95 percent) were tested for HTLV-I and HTLV-II. Of these, 241 (10 percent) HTLV-II-seropositive and 13 (0.5 percent) were HTLV-I-seropositive. On multivariate analysis, independent predictors of HTLV-II infection included injection drug use (OR = 5.2; p < .001), black race (OR = 3.6; p < 0.001), age > 35 years (OR = 3.3; p < .001) and a history of sex with a male injecting drug user (OR = 1.9; p < .001). Among women injected with HIV, the seroprevalence of HTLV-II was 11 percent compared infected with HIV, the seroprevalence of HTLV-II was 11 percent compared with 6 percent for women at risk for HIV but not infected (p < .001). However, HIV was not an independent predictor of HTLV-II infection in multivariate analysis. CONCLUSIONS: This cross sectional analysis confirms that HTLV-II is found commonly in HIV-infected women at risk for HIV in major urban areas throughout the United States and that HTLV-II is far more common than HTLV-I in these populations. Although injecting drug use is most strongly associated with HTLV-II infection, sexual transmission likely contributes to the high HTLV-II seroprevalence in this cohort.(AU)


Assuntos
Feminino , Humanos , Infecções por HIV/complicações , Anticorpos Anti-HTLV-I/sangue , Infecções por HTLV-I/epidemiologia , Anticorpos Anti-HTLV-II/sangue , Infecções por HTLV-II/epidemiologia , Western Blotting , Região do Caribe/etnologia , Estudos de Coortes , Estudos Transversais , Técnica Indireta de Fluorescência para Anticorpo , Infecções por HIV/epidemiologia , Infecções por HTLV-I/complicações , Infecções por HTLV-II/complicações , Modelos Logísticos , Análise Multivariada , Estudos Prospectivos , Abuso de Substâncias por Via Intravenosa/complicações , Estados Unidos/epidemiologia , População Urbana , Fatores de Risco
3.
West Indian med. j ; 40(1): 29-32, Mar. 1991.
Artigo em Inglês | MedCarib | ID: med-10375

RESUMO

The records of patients receiving acute peritoneal dialysis during the 1983 - 1987 were retrospectively evaluated. Of a total of 59 patients receiving dialysis, 10 developed peritonitis. Staphylococcus aureus was the single most frequently isolated organism. However, gram-negative bacilli as a group were more common. We recommend the use of cloxacillin orally and gentamicin intra-peritoneally as empiric antibiotic coverage until results of culture reports are available (AU)


Assuntos
Humanos , Adolescente , Adulto , Pessoa de Meia-Idade , Masculino , Feminino , Peritonite/microbiologia , Diálise Peritoneal/efeitos adversos , Bactérias Gram-Negativas/isolamento & purificação , Estudos Retrospectivos , Peritonite/tratamento farmacológico , Cloxacilina/uso terapêutico , Gentamicinas/uso terapêutico , Fatores de Tempo , Peritonite/etiologia , Peritonite/tratamento farmacológico
4.
West Indian med. j ; 39(Suppl. 1): 26, Apr. 1990.
Artigo em Inglês | MedCarib | ID: med-5297

RESUMO

A retrospective study of all reported smear-positive cases of malaria in Jamaica between 1966 and 1989 was undertaken. There were 76 cases of imported malaria. Fourteen (14) of these cases were seen and treated at the University Hospital of the West Indies or at the University Health Centre. The results and their implications are discussed (AU)


Assuntos
Malária/epidemiologia , Jamaica
6.
West Indian med. j ; 29(2): 117-22, June 1980.
Artigo em Inglês | MedCarib | ID: med-11299

RESUMO

Bananas are known to have a high K+ content. The bioavailability of the K+ in bananas was compared with that in Slow-K tablets in 5 normal subjects. 24-hr urinary K+ excretion was assumed to be an index of K+ absorbed from the gatro-intestinal tract. The results indicate that the K+ in bananasis available, since 24-hr K+ excretion rose significantly during the period of banana consumption. The rise in K+ excretion while taking Slow-K was however, greater, the difference between the two being highly significant (p<0.01). The possible reasons for this difference are discussed. It is suggested that bananas may be a useful and safer alternative to Slow-K for K+ supplementation in patients in whom the extra calories are not contraindicated (AU)


Assuntos
Adulto , Humanos , Masculino , Frutas , Potássio/urina , Disponibilidade Biológica , Creatinina/urina , Preparações de Ação Retardada , Diuréticos/efeitos adversos , Deficiência de Potássio/induzido quimicamente , Deficiência de Potássio/terapia , Potássio/administração & dosagem , Potássio/metabolismo , Sódio/urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...